Welcome
First-in-human trial of a new drug for rheumatoid arthritis
Researchers at King's College London have discovered a potential new treatment for rheumatoid arthritis. A human protein called BiP.
We have just completed recruitment for the clinical trial and will be publishing results in due course.
Welcome to the BiP study website. On this site you will find information about general study aim sand a description of BiP. If you are interested there is more detailed information in the about study details section of the website. Here you will find the detailed inclusion/exclusion criteria, the complete study protocol and other documents related to the study.